Spontaneous Remission of High-Grade Non-Hodgkin Lymphoma After SARS-CoV-2 Infection-Reference-Cited by-同舟云学术

Spontaneous Remission of High-Grade Non-Hodgkin Lymphoma After SARS-CoV-2 Infection

Published:2023-11-29 Issue:2 Volume:49 Page:e77-e79
ISSN:1536-0229
Container-title:Clinical Nuclear Medicine
language:en
Short-container-title:Clin Nucl Med

Author:

Teixeira Ferreira Rita¹,Cardoso Ferreira Inês¹,Carmona Susana¹,Montalvão Ana²,Santos Ana Isabel¹

Affiliation:

1. Nuclear Medicine Department, Hospital Garcia de Orta E.P.E., Almada, Portugal

2. Oncology - Hematology Department, Unidade Local de Saúde do Baixo Alentejo E.P.E., Beja, Portugal.

Abstract

Abstract Despite extensive research into COVID-19 since its emergence in late 2019, there is still much not fully understood about its long-term effects. When infected with SARS-CoV-2, cancer patients have been reported to be at higher risk for unfavorable outcomes. Nevertheless, evidence suggests that viruses may exhibit an antitumor effect in some cases, which has recently been anecdotally reported with SARS-CoV-2. We present the case of a patient with a recent high-grade non-Hodgkin lymphoma diagnosis and without any cancer-specific therapy, in whom a complete metabolic response on 2-[18F]FDG PET/CT was observed after COVID-19.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Radiology, Nuclear Medicine and imaging,General Medicine

Reference10 articles.

1. Spontaneous regression of cancer;Cancer Treat Rev,1996

2. The spontaneous remission of cancer: current insights and therapeutic significance;Transl Oncol,2021

3. SARS-CoV-2 as an oncolytic virus following reactivation of the immune system: a review;Int J Mol Sci,2023

4. Potential molecular mechanisms of rare anti-tumor immune response by SARS-CoV-2 in isolated cases of lymphomas;Viruses,2021

5. Spontaneous cancer remission after COVID-19: insights from the pandemic and their relevance for cancer treatment;J Transl Med,2023